Brief: Somnomed Sees Fy22 Revenue Growth Of At Least 15%

SomnoMed

25/11/2021 01:13

Nov 25 (Reuters) - Somnomed Ltd  SOM.AX :
    * SEES FY22 REVENUE GROWTH OF AT LEAST 15%
    * SEES FY22 EBITDA TO BREAK EVEN, EXPECTED TO REBOUND IN
FY23 AND
BEYOND

Source text for Eikon:  ID:nASX4hm5Wt 
Further company coverage:  SOM.AX 

 ((Reuters.Briefs@thomsonreuters.com;))